2024, Vol 14, No. 3

Editor-in-Chief

Prof. Khosro Adibkia

Review

1. Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy

Sanjay Singh*

Bioimpacts. 2013;3(2): 53-65. doi: 10.5681/bi.2013.007

PMCID: PMC3713871 PMID: 23878788 Scopus ID: 84881502609

Article

PDF

XML

Cited By:

Editorial

2. The challenges of green nanotechnology

Miguel de la Guardia*

Bioimpacts. 2014;4(1): 1-2. doi: 10.5681/bi.2014.009

PMCID: PMC4005277 PMID: 24790892 Scopus ID: 84900478943

Article

PDF

XML

Cited By:

Editorial

3. Nanocosmetics: benefits and risks

Javad Shokri*

Bioimpacts. 2017;7(4): 207-208. doi: 10.15171/bi.2017.24

PMCID: PMC5801531 PMID: 29435427 Scopus ID: 85040988305

Article

PDF

Full Text

XML

Cited By:

Review

4. Engineered nanoparticle bio-conjugates toxicity screening: The xCELLigence cells viability impact

Clarence S Yah* , Geoffrey S. Simate

Bioimpacts. 2020;10(3): 195-203. doi: 10.34172/bi.2020.24

PMCID: PMC7416007 PMID: 32793442 Scopus ID: 85089711934

Article

PDF

Suppl 1

Full Text

XML

Cited By:

The impact of bio-nanomaterials XCELLigence-cytotoxicity testing. A non-invasive in-vitro monitoring process that mimics exact continuous cellular bio-responses. However, to expand and affirm consumer safety concerns of bio-nanomaterials, additional XCELLigence data is required for bio-nanomaterials toxicity protocols and methodological development.

Editorial

5. Therapeutic impacts of enzyme-responsive smart nanobiosystems

Marziyeh Fathi , Azam Safary , Jaleh Barar*

Bioimpacts. 2020;10(1): 1-4. doi: 10.15171/bi.2020.01

PMCID: PMC6977590 PMID: 31988850 Scopus ID: 85078980716

Article

PDF

Full Text

XML

Cited By:

Jaleh Barar (PharmD, PhD) is Professor of Drug Delivery and Targeting. She currently is the chair of the department of Pharmaceutics at the Faculty of Pharmacy, Tabriz university of Medical Sciences. Professor Barar’s research is focused on various aspects of the pharmaceutical cell biology with the particular emphasis on the development of novel drug delivery and targeting strategies to combat cancer.

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons